Virginia, It's Not Just Data Centers Who Are Watching

Ain't Wastin' Time No More; One Way Out - Allman Brothers

Virginia’s Data Center Tax Debate and Its Broader Economic Implications

The Virginia Senate’s proposal to eliminate the sales and use tax exemption for data center equipment raises significant questions about the Commonwealth’s long‑term economic competitiveness and pro-business reputation as a stable place to invest.

The exemption, originally created to attract large‑scale digital infrastructure investment, helped Virginia become the largest data‑center hub in the world, anchoring cloud computing, artificial intelligence, and global internet traffic.

Ending the incentive earlier than expected could slow or end new data‑center development by introducing policy uncertainty.

These facilities require billions of dollars in upfront investment and long planning horizons.

If Virginia signals that major economic development incentives can be changed midstream, companies evaluating new projects may reconsider where to locate future facilities.

The reputational implications extend well beyond the technology sector.

Virginia has recently attracted more than $12 billion in pharmaceutical manufacturing investments, positioning the state as an emerging life‑sciences hub.

Major projects include:

• Eli Lilly announcing a $5 billion manufacturing facility in Goochland County expected to create about 650 permanent jobs and roughly 1,800 construction jobs.

• AstraZeneca developing a $4.5 billion biopharmaceutical manufacturing hub in Albemarle County focused on advanced medicines including cancer and metabolic therapies.

• Merck expanding its pharmaceutical manufacturing presence in the Shenandoah Valley with a multibillion‑dollar facility.

These investments were influenced by Virginia’s reputation for policy stability, workforce quality, and a pro‑business climate.

If Virginia even appears willing to reverse economic incentives after companies commit billions of dollars, it risks undermining that reputation.

Pharmaceutical manufacturers currently evaluating U.S. expansion sites—particularly for complex biologics and advanced drug manufacturing—closely monitor how states treat existing investors.

In a global competition for capital, predictability is often as important as tax policy itself.

The debate over the data‑center exemption is therefore not only about one industry—it is about whether Virginia continues to signal long‑term reliability to the advanced industries it is trying to attract.

It’s one thing to have a rational policy discussion in order to evaluate the efficacy of previous decisions. That’s natural, healthy, and usually productive.

It’s quite another to have a knock down drag out, hostage taking political debate over an industry that has invested TENS of BILLIONS in Virginia out on social media that requires a special - and unnecessary - legislative session.

This ain’t funny - it’s damaging.

The business world is watching this debate and others taking place in other states/cities.

Trust me when I tell you this - if you think politics moves fast, business moves MUCH faster and they run to predictable, reliable markets.

They have enough problems competing in the global marketplace for human and financial capital, they literally don’t have time for these things.

Maybe they could relocate to Georgia.

From the Eat a Peach album a TWOFER!